| Company Name: |
Sinopharm Chemical Reagent Co,Ltd.
|
| Tel: |
86-21-63210123 |
| Email: |
sj_scrc@sinopharm.com |
| Products Intro: |
Product Name:Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol)
CAS:457071-73-7
Package:25 mg
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:N-(3-Butenyl)norbuprenorphine
CAS:457071-73-7
Purity:NULL Package:10mg;25mg;5mg Remarks:NULL
|
|
| | Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) Basic information |
| Product Name: | Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) | | Synonyms: | Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine);N-(3-Butenyl)norbuprenorphine;Buprenorphine Related CoMpound A CII;Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol);Buprenorphine Related Compound A;N-(3-Butenyl)norbuprenorphine (1.0mg/ml in Acetonitrile);6,14-Ethenomorphinan-7-methanol, 17-(3-buten-1-yl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-, (αS,5α,7α)-;Buprenorphine Related compound AQ: What is
Buprenorphine Related compound A Q: What is the CAS Number of
Buprenorphine Related compound A Q: What is the storage condition of
Buprenorphine Related compound A Q: What are the applications of
Buprenorphine Related compound A | | CAS: | 457071-73-7 | | MF: | C29H41NO4 | | MW: | 467.64 | | EINECS: | | | Product Categories: | | | Mol File: | 457071-73-7.mol | ![Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) Structure](CAS/GIF/457071-73-7.gif) |
| | Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) Chemical Properties |
| Boiling point | 590.6±50.0 °C(Predicted) | | density | 1.22±0.1 g/cm3(Predicted) | | solubility | Basic Alcohol (Slightly), Chloroform (Slightly) | | form | Solid | | pka | 9.47±0.60(Predicted) | | color | White to Pale Yellow |
| | Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) Usage And Synthesis |
| Uses | An impurity in the synthesis of Buprenorphine (B689570), which is a controllled substance (narcotic). Analgesic that demonstrates narcotic agonist-antagonist properties. |
| | Buprenorphine Related Compound A CII (25 mg) (21-[3-(1-Propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) Preparation Products And Raw materials |
|